Selected Scholarly Publications

Found 1636 results
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Hattan, C.. M., Shojaie J.., Lau S.. S., & Anders M.. W. (2013).  Synthesis of 3-(1-Methyl-1h-Imidazol-2-Ylthio)Propanoic Acid and (E)-3-(1-Methyl-1h-Imidazol-2-Ylthio)Acrylic Acid. Synthetic Communications. 43, 1-8.
Hsu, M.. Y., Dietrich J.., Hulme C.., & Shaw A.. Y. (2013).  Synthesis of Di- and Tri-Substituted Imidazole-4-carboxylates via PBu3-Mediated [3+2] Cycloaddition. Synthetic Communications. 43, 1538-1542.
Hsu, M.. Y., Dietrich J.., Hulme C.., & Shaw A.. Y. (2013).  Synthesis of Di- and Tri-Substituted Imidazole-4-carboxylates via PBu3-Mediated 3+2 Cycloaddition. Synthetic Communications. 43, 1538-1542.
Chen, Y.. H., Lu P.. J., Hulme C.., & Shaw A.. Y. (2013).  Synthesis of kojic acid-derived copper-chelating apoptosis inducing agents. Medicinal Chemistry Research. 22, 995-1003.
Chen, Y.. H., Lu P.. J., Hulme C.., & Shaw A.. Y. (2013).  Synthesis of kojic acid-derived copper-chelating apoptosis inducing agents. Medicinal Chemistry Research. 22, 995-1003.
Siaki, L.. A., Loescher L.. J., & Trego L.. L. (2013).  Synthesis strategy: building a culturally sensitive mid-range theory of risk perception using literary, quantitative, and qualitative methods. J Adv Nurs. 69, 726-37.
Park, R.., Kim D.. W., & Barrett H.. H. (2013).  Synthetic phase-shifting for optical testing: point-diffraction interferometry without null optics or phase shifters. Opt Express. 21, 26398-417.
Barshes, N.. R., Sigireddi M.., Wrobel J.. S., Mahankali A.., Robbins J.. M., Kougias P.., et al. (2013).  The system of care for the diabetic foot: objectives, outcomes, and opportunities. Diabet Foot Ankle. 4,
Tang, D.. H., Harrington A.. R., Lee J.. K., Lin M.., & Armstrong E.. P. (2013).  A systematic review of economic studies on biological agents used to treat Crohn's disease. Inflamm Bowel Dis. 19, 2673-94.
Tang, D.. H., Harrington A.. R., Lee J.. K., Lin M.., & Armstrong E.. P. (2013).  A systematic review of economic studies on biological agents used to treat Crohn's disease. Inflamm Bowel Dis. 19, 2673-94.
Webber, K.. J., & Loescher L.. J. (2013).  A systematic review of parent role modeling of healthy eating and physical activity for their young African American children. J Spec Pediatr Nurs. 18, 173-88.
Jiang, A.., Wang J.., Joshi M.., & Christoforidis J.. B. (2013).  Systemic treatments for noninfectious vitreous inflammation. Mediators Inflamm. 2013, 515312.
T
Silva, E.. A. Carrera, Chan P.. Y., Joannas L.., Errasti A.. E., Gagliani N.., Bosurgi L.., et al. (2013).  T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response. Immunity. 39, 160-70.
Taylor-Piliae, R. E. (2014).  Tai Ji Quan as an exercise modality to prevent and manage cardiovascular disease: A review. Journal of Sport and Health Science. 3, 43-51.
Martinez-Ariza, G., Dietrich J., De Moliner F., & Hulme C. (2013).  A tandem [3 + 2] cycloaddition-elimination cascade reaction to generate pyrrolo[3,4-c]pyrrole-1,3-diones. Synlett. 24, 1801-1804.
Martinez-Ariza, G., Dietrich J., De Moliner F., & Hulme C. (2013).  A tandem [3 + 2] cycloaddition-elimination cascade reaction to generate pyrrolo[3,4-c]pyrrole-1,3-diones. Synlett. 24, 1801-1804.
Martinez-Ariza, G.., Dietrich J.., De Moliner F.., & Hulme C.. (2013).  A Tandem 3+2 Cycloaddition-Elimination Cascade Reaction to Generate Pyrrolo- 3,4-c pyrrole-1,3-diones. Synlett. 24, 1801-1804.
Eller, J.. L., Jahshan S.., Dumont T.. M., Kan P.., & Siddiqui A.. H. (2013).  Tandem symptomatic internal carotid artery and persistent hypoglossal artery stenosis treated by endovascular stenting and flow reversal. BMJ Case Rep. 2013,
Tao, S.., Zheng Y.., Lau A.., Jaramillo M.. C., Chau B.. T., Lantz R.. C., et al. (2013).  Tanshinone I activates the Nrf2-dependent antioxidant response and protects against As(III)-induced lung inflammation in vitro and in vivo. Antioxid Redox Signal. 19, 1647-61.
Tao, S.., Zheng Y.., Lau A.., Jaramillo M.. C., Chau B.. T., Lantz R.. C., et al. (2013).  Tanshinone I activates the Nrf2-dependent antioxidant response and protects against As(III)-induced lung inflammation in vitro and in vivo. Antioxid Redox Signal. 19, 1647-61.
Ronaldson, P.. T., & Davis T.. P. (2013).  Targeted drug delivery to treat pain and cerebral hypoxia. Pharmacol Rev. 65, 291-314.
Odejide, O.., Weigert O.., Lane A.. A., Toscano D.., Lunning M.. A., Kopp N.., et al. (2013).  A targeted mutational landscape of angioimmunoblastic T cell lymphoma. Blood. 123, 1293-6.
Wang, Y.., Kaiser C.. E., Frett B.., & Li H.. Y. (2013).  Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators. J Med Chem. 56, 5219-30.
Huang, L.. S., Berdyshev E.., Mathew B.., Fu P.., Gorshkova I.. A., He D.., et al. (2013).  Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. Faseb j. 27, 1749-60.
Huang, L.. S., Berdyshev E.., Mathew B.., Fu P.., Gorshkova I.. A., He D.., et al. (2013).  Targeting sphingosine kinase 1 attenuates bleomycininduced pulmonary fibrosis. FASEB Journal. 27, 1749-1760.

Pages